Summit Therapeutics (SMMT) News Today $16.98 -1.59 (-8.56%) (As of 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period 3 No-Brainer Biotech Stocks to Buy With $200 Right NowDecember 18 at 5:44 AM | fool.comSummit Therapeutics Inc. (NASDAQ:SMMT) Shares Sold by State Street CorpState Street Corp lowered its position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 15.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,468,514 shares of the company's stock after seDecember 18 at 3:35 AM | marketbeat.comAnalysts Set Summit Therapeutics Inc. (NASDAQ:SMMT) Price Target at $33.33December 16 at 2:05 AM | americanbankingnews.com2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall StreetDecember 15 at 7:37 AM | fool.comInvesting $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 TodayDecember 14, 2024 | fool.comVirtu Financial LLC Acquires Shares of 42,243 Summit Therapeutics Inc. (NASDAQ:SMMT)Virtu Financial LLC bought a new position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 42,243 shares of the company's stock, valued at approximately $December 14, 2024 | marketbeat.comSummit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 13, 2024 | businesswire.comSummit Therapeutics (NASDAQ:SMMT) Now Covered by Wells Fargo & CompanyDecember 13, 2024 | americanbankingnews.comWells Fargo & Company Begins Coverage on Summit Therapeutics (NASDAQ:SMMT)Wells Fargo & Company began coverage on shares of Summit Therapeutics in a research note on Wednesday. They set an "overweight" rating and a $30.00 target price for the company.December 11, 2024 | marketbeat.com31,300 Shares in Summit Therapeutics Inc. (NASDAQ:SMMT) Purchased by Polar Asset Management Partners Inc.Polar Asset Management Partners Inc. bought a new position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 31,300 shares of the company's stockDecember 7, 2024 | marketbeat.comJefferies Initiates Coverage of Summit Therapeutics (SMMT) with Buy RecommendationDecember 6, 2024 | msn.comWhy Summit Therapeutics Stock Rocketed 6% Higher on FridayDecember 6, 2024 | fool.comSummit Therapeutics (NASDAQ:SMMT) Coverage Initiated at Jefferies Financial GroupJefferies Financial Group began coverage on Summit Therapeutics in a research report on Friday. They issued a "buy" rating and a $31.00 price target on the stock.December 6, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Boosts Stock Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT)The Manufacturers Life Insurance Company increased its position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 43.5% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 295,629 shares of the company's stoDecember 6, 2024 | marketbeat.comBank of Montreal Can Buys Shares of 97,575 Summit Therapeutics Inc. (NASDAQ:SMMT)Bank of Montreal Can purchased a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 97,575 shares of the company's stock, valued at approximately $2,038,0December 6, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Raises Position in Summit Therapeutics Inc. (NASDAQ:SMMT)Charles Schwab Investment Management Inc. increased its holdings in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 53.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,432,713 shares of the coDecember 4, 2024 | marketbeat.comSummit Therapeutics Inc. (NASDAQ:SMMT) Shares Acquired by Fmr LLCFmr LLC increased its holdings in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 9.8% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 8,303,119 shares of the company's stock after acquiring an additionalDecember 3, 2024 | marketbeat.comBaker BROS. Advisors LP Purchases 1,202,643 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT)Baker BROS. Advisors LP boosted its position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 5.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,424,865 shares of the company's stock after puDecember 2, 2024 | marketbeat.comBillionaire Ken Griffin Is Selling Palantir and Buying a Stock Wall Street Expects to Rocket 139% HigherDecember 2, 2024 | fool.com99,442 Shares in Summit Therapeutics Inc. (NASDAQ:SMMT) Bought by Cerity Partners LLCCerity Partners LLC bought a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 99,442 shares of the company's sDecember 2, 2024 | marketbeat.comWarning: This Skyrocketing Stock Has a Hidden RiskNovember 30, 2024 | fool.comIntech Investment Management LLC Takes $694,000 Position in Summit Therapeutics Inc. (NASDAQ:SMMT)Intech Investment Management LLC purchased a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 31,680 shares of the company's stock, valued at apNovember 30, 2024 | marketbeat.comSummit Therapeutics to Present at Upcoming Investor ConferencesNovember 26, 2024 | finance.yahoo.com3 Monster Stocks in the MakingNovember 23, 2024 | fool.comSummit Therapeutics' (SMMT) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $44.00 price objective on shares of Summit Therapeutics in a report on Monday.November 18, 2024 | marketbeat.comMarketBeat Week in Review – 11/4 - 11/8 (SMMT)Markets rallied strongly this week on clarity about the election and an expected rate cut, but next week's inflation readings will determine if momentum lastsNovember 9, 2024 | marketbeat.com2 Hot Biopharma Stocks to Buy and Hold for 5 YearsNovember 8, 2024 | fool.comWhy Summit Therapeutics Stock Was a Winner TodayNovember 4, 2024 | fool.comSummit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And OpdivoNovember 4, 2024 | benzinga.comSummit Therapeutics: Is Their Lung Cancer Drug a Game Changer?Summit Therapeutics Inc. aims to advance Ivonescimab, a potential breakthrough for NSCLC. The FDA's Fast Track designation boosts its U.S. clinical pathway.November 4, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Coverage Initiated by Analysts at JMP SecuritiesJMP Securities began coverage on shares of Summit Therapeutics in a report on Monday. They set a "market outperform" rating and a $32.00 target price for the company.November 4, 2024 | marketbeat.com3 Magnificent Stocks Under $100 to Buy in NovemberNovember 3, 2024 | fool.comabrdn plc Takes $24.89 Million Position in Summit Therapeutics Inc. (NASDAQ:SMMT)abrdn plc bought a new position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,136,286 shares of the company's stock, valued at approNovember 1, 2024 | marketbeat.comDecoding Summit Therapeutics Inc (SMMT): A Strategic SWOT InsightNovember 1, 2024 | uk.finance.yahoo.comSummit Therapeutics price target lowered to $44 from $45 at H.C. WainwrightNovember 1, 2024 | markets.businessinsider.comSummit Therapeutics Inc. (NASDAQ:SMMT) Q3 2024 Earnings Call TranscriptOctober 31, 2024 | insidermonkey.comHC Wainwright Has Lowered Expectations for Summit Therapeutics (NASDAQ:SMMT) Stock PriceHC Wainwright lowered their price objective on Summit Therapeutics from $45.00 to $44.00 and set a "buy" rating on the stock in a research report on Thursday.October 31, 2024 | marketbeat.com3 Stocks That Have Generated 1,000% Returns in Just 2 YearsOctober 31, 2024 | fool.comSummit Therapeutics (NASDAQ:SMMT) Shares Down 10.4% - Here's What HappenedSummit Therapeutics (NASDAQ:SMMT) Shares Down 10.4% - Time to Sell?October 30, 2024 | marketbeat.comChina Universal Asset Management Co. Ltd. Has $3.05 Million Stock Position in Summit Therapeutics Inc. (NASDAQ:SMMT)China Universal Asset Management Co. Ltd. boosted its holdings in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 69.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 139,352 shares of the coOctober 29, 2024 | marketbeat.comIs Summit Therapeutics a Millionaire Maker?October 27, 2024 | fool.comSummit Therapeutics Inc. (SMMT): An Unstoppable Stock That Could Make You RicherOctober 27, 2024 | finance.yahoo.comPublic company CEOs pay $33M for Brickell penthouse (Photos)October 24, 2024 | bizjournals.comSummit Therapeutics (SMMT) Scheduled to Post Quarterly Earnings on WednesdaySummit Therapeutics (NASDAQ:SMMT) will be releasing earnings before the market opens on Wednesday, October 30, Zacks reports.October 24, 2024 | marketbeat.comBillionaire Bob Duggan Snags $33M Miami Penthouse Amid Summit Therapeutics 689% Stock RallyOctober 24, 2024 | msn.comUp Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising?October 24, 2024 | fool.comExchange Traded Concepts LLC Sells 39,252 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT)Exchange Traded Concepts LLC reduced its stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 85.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,499 shOctober 23, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Trading 0.4% Higher - Still a Buy?Summit Therapeutics (NASDAQ:SMMT) Trading Up 0.4% - Should You Buy?October 22, 2024 | marketbeat.comBillionaire Israel Englander Just Quietly Took a Stake in This Potentially Lucrative Pharmaceutical Stock. Should You?October 22, 2024 | fool.comSummit Therapeutics (NASDAQ:SMMT) Trading Up 0.8% - Here's What HappenedSummit Therapeutics (NASDAQ:SMMT) Stock Price Up 0.8% - Here's What HappenedOctober 21, 2024 | marketbeat.com Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address An extra $2 trillion a year for this industry? (Ad)We're on the cusp of an energy revolution... I'm not talking about lithium batteries, renewable energies, or nuclear energy. This 'silent energy boom' is bigger than anything we've seen before. Click here for the shocking truth SMMT Media Mentions By Week SMMT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SMMT News Sentiment▼0.800.48▲Average Medical News Sentiment SMMT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SMMT Articles This Week▼84▲SMMT Articles Average Week Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News Today BioNTech News Today Teva Pharmaceutical Industries News Today BeiGene News Today Moderna News Today Viatris News Today Genmab A/S News Today Dr. Reddy's Laboratories News Today Sarepta Therapeutics News Today Catalent News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SMMT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMMT Stock Alerts